Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Korean J Anesthesiol ; 57(5): 662-665, 2009 Nov.
Article in English | MEDLINE | ID: mdl-30625944

ABSTRACT

Obstetric anesthesia in a parturient with severe osteogenesis imperfecta is challenging in many aspects, particularly concerning maternal pathophysiological problems and the technical difficulties of anesthesia. Here, we report a case of successful spinal anesthesia, instead of general or epidural anesthesia, during a cesarean delivery in a patient with severe osteogenesis imperfecta.

2.
Yonsei Med J ; 43(4): 420-6, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12205728

ABSTRACT

A randomized prospective study was performed on the anesthetic induction, maintenance, and recovery characteristics of sevoflurane-nitrous oxide, compared to that of target- controlled propofol and fentanyl anesthesia, for forty day-case hysteroscopic surgery. The patients in the sevoflurane group (n = 20) received sevoflurane-nitrous oxide for both induction (8%) and maintenance (1 - 2%) of anesthesia, while the patients in the propofol group (n = 20) received target-controlled propofol (4 micro g/ml, 3-6 micro g/ml as occasion demanded) with fentanyl (1 micro g/kg). In both groups, the airway was maintained by a facemask with the patient breathing spontaneously during the surgery. The mean times to unconsciousness and readiness for surgery were similar in both groups, with those for the sevoflurane group, compared to the propofol group being 80.4 +/- 18.9 vs. 83.6 +/- 38.8 sec, and 220.1 +/- 76.9 vs. 231.0 +/- 95.4 sec, respectively. Propofol was associated with significantly higher incidences of involuntary movement (30% vs. 5%) and apnea (35% vs. 0%) during the induction period than with sevoflurane. Hemodynamic variables were similar with the exception of significantly lower blood pressures during the first 5 minutes of induction with propofol. Emergence times to eye opening, hand squeezing and orientation for sevoflurane compared to propofol were: 316.6 +/- 79.3 vs. 507.4 +/- 218.8 sec, 390.0 +/- 69.3 vs. 653.1 +/- 201.6 sec and 380.6 +/- 80.8 vs. 666.3 +/- 208.7 sec, respectively, all of these being significantly faster for sevoflurane than propofol. The postanesthetic Aldrete's recovery scores of the patients immediately after surgery were higher in the sevoflurane group. Propofol was associated with more drowsiness, with sevoflurane being associated with more nausea, in the recovery period; however, neither delayed the time to discharge (103.7 +/- 28.1 vs. 99.0 +/- 36.2 min). In conclusion, sevoflurane-nitrous oxide appears to be superior for day-case hysteroscopic surgery, than target-controlled propofol with fentanyl, with regards to the speed of recovery from anesthesia and the return to hemodynamic stability.


Subject(s)
Anesthetics/pharmacology , Fentanyl/pharmacology , Hysteroscopy , Methyl Ethers/pharmacology , Nitrous Oxide/pharmacology , Propofol/pharmacology , Adult , Anesthesia , Female , Hemodynamics/drug effects , Humans , Methyl Ethers/administration & dosage , Nitrous Oxide/administration & dosage , Pain Measurement , Propofol/administration & dosage , Prospective Studies , Sevoflurane
SELECTION OF CITATIONS
SEARCH DETAIL